During the past decade, Semmelweis Egyetem, Szemészeti Klinika conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Semmelweis Egyetem, Szemészeti Klinika" are "Age-Related Macular Degeneration" (1 trials), "Macular Edema" (1 trials), "Macular Edema, Diabetic" (1 trials) and "Retinal Vein Occlusion" (1 trials). Many other conditions were trialed in "Semmelweis Egyetem, Szemészeti Klinika" in a lesser frequency.

Most popular intervention types in "Semmelweis Egyetem, Szemészeti Klinika" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "IVT aflibercept" (1 trials), "Lucentis (ranibizumab)" (1 trials), "Masked Sham Therapy" (1 trials), "PF-04634817" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Semmelweis Egyetem, Szemészeti Klinika" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Semmelweis Egyetem, Szemészeti Klinika". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Semmelweis Egyetem, Szemészeti Klinika, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Semmelweis Egyetem, Szemészeti Klinika, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".